OPTION CARE HEALTH, INC.

OPCH

CIK 0001014739 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$1.47B
↑+8.8% +$119Mvs FY2024 (Q4)
Operating Income
$92M
↑+5.1% +$4Mvs FY2024 (Q4)
Net Income
$59M
↓-2.7% -$2Mvs FY2024 (Q4)
Gross Profit
$283M
↑+5.4% +$15Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
53/100
  • Profitability
    25ROIC 9.9% (10% = solid, 20%+ = moat)
  • Liquidity
    51Current Ratio 1.53 (above 1.5 = solid)
  • Leverage
    56D/E 0.88 (under 0.5 = conservative)
  • Efficiency
    100Asset Turnover 1.64x (1.0+ = capital-efficient)
  • Growth
    46Revenue YoY +8.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    42Op Margin 6.2% · trend -0.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project OPCH's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -2.2%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$18.56
Total enterprise IV
$3.03B
Diluted shares
0.16B
Terminal PV
$2.14B (70% of total)
Year-5 FCF
$252M
YearProjected FCFDiscounted PV
+1$224M$203M
+2$230M$190M
+3$237M$178M
+4$244M$167M
+5$252M$156M
Terminal$3.44B$2.14B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$41M
investment in PP&E
Stock buybacks (TTM)
$158M
share count reduction
Stock-based comp (TTM)
$40M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$3.46B
everything owned
Total liabilities
$2.13B
everything owed
Stockholders' equity
$1.33B
shareholder claim
Net debt
$928M
LT debt minus cash

Recent performance · 71 quarters

Revenue↑+8.8% +$119M
$1.47B
Net Income↓-2.7% -$2M
$59M
Free Cash Flow↓-13.7% -$4M
$22M
Operating Margin↓-0.2pts
6.2%

Drill down